Oxolinic Acid

Oxolinic Acid

SCHEMBL637058

CCn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3.CCn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 1.00
ALDH1A1 P00352 7/20 1.00
HPGD P15428 5/20 1.00
HSD17B10 Q99714 4/20 1.00
CYP1A2 P05177 1/20 1.00
CYP2D6 P10635 1/20 1.00
APEX1 P27695 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
PDE4A P27815 1/20 0.60
PDE4B Q07343 1/20 0.60
PDE4C Q08493 1/20 0.60
PDE4D Q08499 1/20 0.60
TSHR P16473 3/20 0.58
RAB9A P51151 1/20 0.58
LMNA P02545 4/20 0.57
BLM P54132 1/20 0.57
PMP22 Q01453 1/20 0.57
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
HTT P42858 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxolinic Acid SCHEMBL28034345 1.00 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10CYP1A2
Oxolinic Acid SCHEMBL29420856 1.00 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10CYP1A2
Oxolinic Acid SCHEMBL24445 1.00 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10CYP1A2
Oxolinic Acid SCHEMBL27985461 0.99 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10CYP1A2
Oxolinic Acid SCHEMBL28034329 0.99 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10CYP1A2
Oxolinic Acid SCHEMBL27794976 0.99 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10CYP1A2
Oxolinic Acid SCHEMBL30829037 0.99 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10CYP1A2
Oxolinic Acid SCHEMBL3467839 0.99 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10CYP1A2
Oxolinic Acid SCHEMBL28034316 0.99 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10CYP1A2
Oxolinic Acid SCHEMBL27934312 0.99 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4469044-B1 IONIC-LIQUID-BASED FORMULATIONS FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES UNIV AVEIRO (PT) 2026-04-08 EP disclosed
US-12514845-B2 Ionic-liquid-based formulations for the prevention or treatment of neurological diseases UNIVERSIDADE DE AVEIRO (PT) 2026-01-06 US disclosed
US-20240415815-A1 IONIC-LIQUID-BASED FORMULATIONS FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES UNIVERSIDADE DE AVEIRO (PT) 2024-12-19 US disclosed
EP-4469044-A1 IONIC-LIQUID-BASED FORMULATIONS FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES Universidade de Aveiro (PT) 2024-12-04 EP disclosed
US-8163674-B2 Agricultural chemical composition in granular form NIPPON SODA CO., LTD. (JP) 2012-04-24 US disclosed
EP-1498030-B1 GRANULAR AGRICULTURAL-CHEMICAL COMPOSITION KUMIAI CHEMICAL INDUSTRY CO (JP) 2012-02-22 EP disclosed
WO-2010078258-A1 COMPOUNDS COMPRISING TWO OR MORE BIOLOGICALLY FUNCTIONAL IONS AND METHOD OF TREATING PARKINSON'S DISEASE THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2010-07-08 WO disclosed
US-7160841-B2 Uniformly spreadable granular agricultural chemicals formulation and method for scattering (applying) thereof KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2007-01-09 US disclosed
US-20020155955-A1 Solid agricultural chemicals composition, preparation thereof and the method for scattering the same KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2002-10-24 US disclosed
WO-1997036471-A1 GELATIN-BASED COATINGS FOR PLANT SEEDS AND PROPAGULES MONSANTO COMPANY (US) 1997-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240415815-A1 IONIC-LIQUID-BASED FORMULATIONS FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES NOX1, NOX3, NOX4 KDM4E 2911/4885ALDH1A1 318/4885HPGD 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.